Your session is about to expire
← Back to Search
Hormone Therapy for Breast Cancer
Study Summary
This trial is testing a new way to give anti-estrogen treatment to women with breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Neoadjuvant endocrine therapy treatment (physician's choice)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
How many individuals are allowed to enroll in this clinical trial?
"This study is not presently enrolling patients. The listing was first created on February 5th, 2017 and updated September 22nd, 2020. For other active trials, there are currently 2700 clinical studies for breast cancer and 234 for Tamoxifen that are admitting new participants."
What are the common benefits of Tamoxifen?
"malignant neoplasms is commonly treated with Tamoxifen. Tamoxifen is also effective at treating other conditions including ovarian cancer, breast cancer, and high risk."
What is the typical patient experience with Tamoxifen?
"While Phase 2 trials don't have efficacy data, there is some safety evidence for Tamoxifen. Therefore, it received a score of 2."
What are the goals that we hope to achieve with this experiment?
"The key metric that will be evaluated four weeks after treatment starts is the increase in HER protein levels. Other measures of success include the number of subjects who achieve partial or complete radiographic response, as defined by World Health Organization (WHO) criteria."
Could you give me a rundown of other research done on Tamoxifen?
"Out of the 234 ongoing studies that involve Tamoxifen, 66 are in Phase 3. While some trials take place in Shanghai, there are 16109 different locations around the world where researchers are studying this medication."
Can new patients still join this clinical trial?
"Unfortunately, this particular clinical trial is not presently enrolling patients. Although, there are 2934 other active trials that might be a better match for you. This study was first posted on February 5th, 2017 and was last updated on September 22nd, 2022."
Share this study with friends
Copy Link
Messenger